Merus to Participate in a Fireside Chat at the 21st Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company, announced that its CEO, Bill Lundberg, M.D., will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on April 13 from 10:15-10:55 a.m. ET. The event will be accessible via a live webcast on the Company's investor page, with an archived version available afterward. Merus specializes in developing innovative multispecific antibodies, including its unique Biclonics® and Triclonics®, which show promise in clinical studies.

UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 06, 2022 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13 at 10:15-10:55 a.m. ET.

The webcast of the fireside chat will be contemporaneously available on the Investors page of the Company's website. The archived presentation will also be available there for a limited time after the event.

About Merus
Merus is a clinical-stage oncology company developing innovative full-length human bispecific and trispecific antibody therapeutics, referred to as Multiclonics®. Multiclonics® are manufactured using industry standard processes and have been observed in preclinical and clinical studies to have several of the same features of conventional human monoclonal antibodies, such as long half-life and low immunogenicity. For additional information, please visit Merus’ website and twitter.

FAQ

What is the date and time of Merus' fireside chat at the Needham Virtual Healthcare Conference?

The fireside chat is scheduled for April 13, 2022, from 10:15 to 10:55 a.m. ET.

Who will represent Merus at the Needham Virtual Healthcare Conference?

Bill Lundberg, M.D., President and CEO of Merus, will participate in the event.

Where can I watch the Merus fireside chat?

The fireside chat will be available via live webcast on Merus' investor page.

Is there an archive of the Merus conference presentation available?

Yes, an archived version of the presentation will be available on the investor page for a limited time after the event.

What kind of products does Merus develop?

Merus develops innovative multispecific antibodies, including Biclonics® and Triclonics®.